Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QAME | ISIN: US92556V1061 | Ticker-Symbol: VIA
Xetra
03.07.25 | 17:35
7,884 Euro
-0,08 % -0,006
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
S&P 500
1-Jahres-Chart
VIATRIS INC Chart 1 Jahr
5-Tage-Chart
VIATRIS INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,8447,94408:44
7,8447,94408:44
ACCESS Newswire
424 Leser
Artikel bewerten:
(2)

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

PITTSBURGH, PA / ACCESSWIRE / October 8, 2024 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024. This is the fourth year in a row that Viatris has received this recognition, which is presented by Forbes and Statista, the world-leading statistics portal and industry ranking provider.

"Our colleagues' passion for and commitment to their work, the patients we serve and our mission of empowering people worldwide to live healthier at every stage of life has made this recognition possible," said Andrew Enrietti, Chief People Officer, Viatris. "Being named by Forbes as one of the World's Best Employers demonstrates our focus on our people and our strong culture - one that prioritizes well-being, promotes inclusivity and diversity, offers growth opportunities, and ensures a healthy work-life balance."

The World's Best Employers for 2024 were selected through an independent survey encompassing a vast sample of over 300,000 participants across 50 different countries. Respondents from around the world gave their "willingness to recommend" their employer on a scale from 1 to 10 and, in addition, had the opportunity to review their company across various aspects of employment. Respondents also had the opportunity to review recent and previous employers. Finally, participants were given the chance to provide their public perception of other employers active within their country and industry. Overall, the award reinforces a company's reputation for providing excellent opportunities for their employees and being among the best places to work in the world.

To learn more about Viatris' performance-driven, highly engaging and inclusive culture, please visit its careers site. You can also learn more by reading its 2023 Sustainability Report, which outlines the company's 2023 achievements and progress across key areas including Access and Global Health, Our People, the Environment and the Community.

Being named to Forbes' list of World's Best Employers 2024 follows Viatris' inclusion on TIME's World's Most Sustainable Companies 2024 list, USA Today's list of America's Climate Leaders 2024 and 3BL's 100 Best Corporate Citizens of 2023 Ranking. The Company has also received Great Place to Work® certifications and Top Employers certifications in multiple countries, among others.

About Viatris
Viatris Inc. (NASDAQ:VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

SOURCE Viatris Inc.

For further information: MEDIA, +1.724.514.1968, Communications@viatris.com, Jennifer Mauer, Jennifer.Mauer@viatris.com, Matt Klein, Matthew.Klein@viatris.com; INVESTORS, +1.412.707.2866, InvestorRelations@viatris.com, Bill Szablewski, William.Szablewski@viatris.com

View additional multimedia and more ESG storytelling from Viatris on 3blmedia.com.

Contact Info:
Spokesperson: Viatris
Website: https://www.3blmedia.com/profiles/viatris
Email: info@3blmedia.com

SOURCE: Viatris



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.